Jim Simons Abcam PLC Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.54 - $24.41 $5.51 Million - $6.24 Million	255,800 Added 71.65%	612,800 $13.9 Million
Q2 2023 Aug 11, 2023	BUY	$12.62 - $24.47 $1.69 Million - $3.28 Million	134,000 Added 60.09%	357,000 $8.74 Million
Q1 2023 May 12, 2023	BUY	$12.98 - $17.1 $1.36 Million - $1.79 Million	104,951 Added 88.9%	223,000 $3 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $389,760 - $476,000	28,000 Added 31.09%	118,049 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $65,464 - $82,075	4,900 Added 5.75%	90,049 $1.35 Million
Q2 2022 Aug 12, 2022	BUY	$12.69 - $19.25 $442,881 - $671,825	34,900 Added 69.45%	85,149 $1.23 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.89 $212,350 - $327,293	13,700 Added 37.48%	50,249 $919,000
Q4 2021 Feb 11, 2022	SELL	$20.04 - $23.84 $502,963 - $598,336	-25,098 Reduced 40.71%	36,549 $861,000
Q3 2021 Nov 12, 2021	BUY	$17.38 - $21.54 $207,725 - $257,446	11,952 Added 24.05%	61,647 $1.25 Million
Q2 2021 Aug 13, 2021	BUY	$18.47 - $22.11 $917,866 - $1.1 Million	49,695 New	49,695 $946,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.